Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
CNS Neuroscience & Therapeutics|May 25, 2024
Autophagy-associated non-coding RNAs: Unraveling their impact on Parkinson's disease pathogenesisMd Sadique Hussain, Ehssan Moglad, Muhammad Afzal, et al.
Journal of Cancer|September 6, 2023
Molecular Targets of Aptamers in Gastrointestinal Cancers: Cancer Detection, Therapeutic Applications, and Associated MechanismsKhang Wen Goh, Annatasha Stephen, Yuan Seng Wu, et al.
Frontiers in Pharmacology|October 2, 2023
Neuroprotective potential of Marsilea quadrifolia Linn against monosodium glutamate-induced excitotoxicity in ratsArunkumar Subramanian, T Tamilanban, Mahendran Sekar, et al.
Nanomaterials (Basel, Switzerland)|October 23, 2021
Ultraflexible Liposome Nanocargo as a Dermal and Transdermal Drug Delivery SystemKalvatala Sudhakar, Shivkanya Fuloria, Vetriselvan Subramaniyan, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 2024
From nature to nanotechnology: The interplay of traditional medicine, green chemistry, and biogenic metallic phytonanoparticles in modern healthcare innovation and sustainabilityAbhijeet Puri, Popat Mohite, Swastika Maitra, et al.
Chemico-Biological Interactions|November 7, 2021
A review on epidermal growth factor receptor's role in breast and non-small cell lung cancerVetriselvan Subramaniyan, Shivkanya Fuloria, Gaurav Gupta, et al.
Frontiers in Pharmacology|April 14, 2023
Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapyNaveen Kumar Velayutham, Tamilanban Thamaraikani, Shadma Wahab, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2023
Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and ChemoresistanceNur Syafiqah Rahim, Yuan Seng Wu, Maw Shin Sim, et al.
Pageof 22